Pediatric endocardial temporary pacemaker implantation: Clinical characteristics and outcomes from a Chinese National Regional Health Center

Abstract

Endocardial temporary pacemakers (TP) are widely used in the treatment of cardiovascular diseases in adults, but their application and clinical experience in the treatment of pediatric cardiovascular cases are relatively limited. This study aims to share the experience of using endocardial TP at a pediatric medical center in China. The study included patients who received their first endocardial TP implantation in the Department of Cardiology at Children's Hospital of Chongqing Medical University, China, from 2016 to 2022. A retrospective analysis of their clinical data was conducted. Our study involved 45 children who underwent endocardial TP implantation. Among these, 25 children (55.56%) converted to sinus rhythm after pacemaker parameter adjustment and the pacemaker was successfully removed; 13 children (28.89%) did not recover sinus rhythm and ultimately required a permanent pacemaker; in 4 cases, the family refused permanent pacemaker implantation; in 1 case, the treatment was abandoned by the family; and 2 children died during hospitalization. Notably, among the 20 children with fulminant myocarditis (FM), 16 children (80.00%) converted to sinus rhythm after pacemaker parameter adjustment and the pacemaker was successfully removed; 3 children (15.00%) ultimately received a permanent pacemaker; and 1 child died during hospitalization. Endocardial TP have shown remarkable efficacy in the treatment of critical heart disease, especially FM.

Keywords

children / endocardial temporary pacemakers / national regional medical center

References

[1] Das G, Carlblom D. Artificial cardiac pacemakers. Int J Clin Pharmacol Ther Toxicol. 1990; 28(5): 177-189.

[2] Gregoratos G. Indications and recommendations for pacemaker therapy. Am Fam Physician. 2005; 71(8): 1563-1570.

[3] Sideris S, Archontakis S, Dilaveris P, et al. Leadless Cardiac Pacemakers: current status of a modern approach in pacing. Hellenic J Cardiol. 2017; 58(6): 403-410.

[4] Toogood G. Pacemaker therapies in cardiology. Aust Fam Physician. 2007; 36(7). 518-519, 521-524.

[5] Tjong FVY, de Ruijter UW, Beurskens NEG, Knops RE. A comprehensive scoping review on transvenous temporary pacing therapy. Neth Heart J. 2019; 27(10): 462-473.

[6] Liang X.-Q, Evans SM, Sun Y.-F. Development of the cardiac pacemaker. Cell Mol Life Sci. 2017; 74(7): 1247-1259.

[7] Takeuchi D, Tomizawa Y. Pacing device therapy in infants and children: a review. J Artif Organs. 2013; 16(1): 23-33.

[8] Kabbani MS, Al Taweel H, Kabbani N, Al Ghamdi S. Critical arrhythmia in postoperative cardiac children: recognition and management. Avicenna J Med. 2017; 7(3): 88-95.

[9] Li T.-T, Cheng J. Clinical analysis of temporary pacemaker implantation in 13 children. Transl Pediatr. 2022; 11(2): 174-182.

[10] Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021; 42(35): 3427-3520.

[11] Members WC, Shah MJ, Silka MJ, et al. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients. Heart Rhythm. 2021; 18(11): 1888-1924.

[12] Ohki S, Hosokawa K, Tomioka S, et al. Pediatric fulminant myocarditis in Japan: a retrospective nationwide database study of hospital volume, management practices, and mortality. Pediatr Crit Care Med. 2021; 22(7): e391-e401.

[13] Sharma AN, Stultz JR, Bellamkonda N, Amsterdam EA. Fulminant myocarditis: epidemiology, pathogenesis, diagnosis, and management. Am J Cardiol. 2019; 124(12): 1954-1960.

[14] Tancredi RG, McCallister BD, Mankin HT. Temporary transvenous catheter-electrode pacing of the heart. Circulation. 1967; 36(4): 598-608.

RIGHTS & PERMISSIONS

2024 The Author(s). Pediatric Discovery published by John Wiley & Sons Australia, Ltd on behalf of Children's Hospital of Chongqing Medical University.